Effects of zonisamide in the treatment of alcohol dependence

Clinical Neuropharmacology

Volumn 33, Issue 5, 2010, Pages 250-253

  Rubio, Gabriel ^a   López Muñoz, Francisco ^b   Ferre, Francisco ^c   Martínez Gras, Isabel ^a   Ponce, Guillermo ^a   Pascual, José M ^c   Jiménez Arriero, Miguel A ^a   Alamo, Cecilio ^b  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

alcohol dependence; anticonvulsant drugs; craving; zonisamide

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; PLACEBO; ZONISAMIDE;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANOREXIA; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DIZZINESS; DOSE TIME EFFECT RELATION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; MALE; MULTICENTER STUDY; OPEN STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SIDE EFFECT; SOMNOLENCE; STATISTICAL SIGNIFICANCE; STRUCTURED INTERVIEW; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ANALOG SCALE; WEIGHT REDUCTION;

ADULT; ALCOHOL DETERRENTS; ALCOHOLISM; ANTICONVULSANTS; DRINKING BEHAVIOR; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; ISOXAZOLES; MALE; OUTPATIENTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77957994534     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNF.0b013e3181f0ed9a     Document Type: Article

References (34)

1. Rehm J, Room R, Van den Brink W, et al. Alcohol use disorders in EU countries and Norway: an overview of the epidemiology. Eur Neuropsychopharmacol 2005;15:377Y388.
2. Rubio G, Jiménez-Arriero MA, Ponce G, et al. Naltrexone versus acamprosate: 1 year follow-up alcohol dependence treatment. Alcohol Alcoholism 2001;36:419Y425.
3. Malcolm R, Myrick H, Brady KT, et al. Update on anticonvulsants for the treatment of alcohol withdrawal. Am J Addict 2001; 10(suppl 1):16Y23.
4. Kenna GA, Lomastro TL, Schiesl A, et al. Review of topiramate: an antiepileptic for the treatment of alcohol dependence. Curr Drug Abuse Rev 2009;2:135Y142.
5. Mueller TI, Stout RL, Rudden S, et al. A double-blind, placebo-controlled pilot study of carbamazepine for the treatment of alcohol dependence. Alcohol Clin Exp Res 1997;21:86Y92.
6. Salloum IM, Conelius JR, Daley DC, et al. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study. Arch Gen Psychiatry 2005;62:37Y45.
7. Rubio G, López-Mun'oz F, Alamo C. Effects of lamotrigine in patients with bipolar disorder and alcohol dependence. Bipolar Disord 2006;8:289Y293.
8. Rubio G, Ponce G, Jiménez-Arriero MA, et al. Effects of topiramate in the treatment of alcohol dependence. Pharmacopsychiatry 2004;37:37Y40.
9. Johnson BA, Rosenthal N, Capece JA, et al. Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA 2007;298:1641Y1651.
10. Flórez G, Garc?́a-Portilla P, Alvarez S, et al. Using topiramate or naltrexone for the treatment of alcohol-dependent patients. Alcohol Clin Exp Res 2008;32:1251Y1259.
11. Martinotti G, Di Nicola M, Romanelli R, et al. High and low dosage oxcarbazepine versus naltrexone for the prevention of relapse in alcohol-dependent patients. Hum Psychopharmacol Clin Exp 2007;22:149Y156.
12. Bialer M. New antiepileptic drugs that are second generation to existing antiepileptic drugs. Exp Opin Invest Drugs 2006;15:637Y647.
13. Baulac M. Introduction to zonisamide. Epilepsy Res 2006; 68(suppl 2):S3YS9.
14. Frampton JE, Scott LJ. Zonisamide. A review of its use in the management of partial seizures in epilepsy. CNS Drugs 2005;19: 347Y367.
15. Kothare SV, Kaleyias J. Zonisamide: review of pharmacology, clinical efficacy, tolerability, and safety. Expert Opin Drug Metab Toxicol 2008;4:493Y506.
16. McElroy SL, Guerdjikova AI, Martens B, et al. Role of antiepileptic drugs in the management of eating disorders. CNS Drugs 2009;23: 139Y156.
17. Sarid-Segal O, Knapp CM, Burch W, et al. The anticonvulsant zonisamide reduces ethanol self-administration by risky drinkers. Am J Drug Alcohol Abuse 2009;35:316Y319.
18. Marlatt G, Gordon JR. Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors. New York: Guilford Press; 1985.
19. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
20. Firsts MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders Patient Edition (SCID-IP, Version 2.0). New York: Biometric Research, New York State Psychiatric Institute; 1995.
21. Sullivan JT, Sykora K, Schneiderman J, et al. Assessment of alcohol withdrawal: the revised Clinical Institute Withdrawal Assessment for Alcohol Scale (CIWA-AR). Br J Addict 1989;84:1353Y1357.
22. Rubio G, Urosa B, Santo-Domingo J. Validación de la escala de la intensidad de la dependencia alcohó lica. Psiquiatr Biol 1998; 5(suppl 1):44Y47.
23. Sobell LC, Sobell MB, Leo GI, et al. Reliability of a timeline method: assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations. Br J Addict 1998;83:393Y402.
24. Miller WR. Form 90: a structured assessment interview for drinking and related behaviors test manual. In: Mattson ME, Marshall LA, eds. NIAAA Project Match Monograph Series, Vol 5. Rockville, MD: National Institute on Alcoholism and Alcohol Abuse; 1996.
25. Jiménez M, Monasor R, Jiménez-Arriero MA, et al. Programas Psicológicos de intervención en los trastornos por uso de alcohol. In: Curso de Especialización en Alcoholismo. Madrid: FAD; 2001:9.1Y9.47.
26. Swift RM. Medications and alcohol craving. Alcohol Res Health 1999;23:207Y213.
27. Knapp CM, Mercado M, Markley TL, et al. Zonisamide decreases ethanol intake in rats and mice. Pharmacol Biochem Behav 2007;87:65Y72.
28. Rogawski MA, Löscher W. The neurobiology of antiepileptic drugs. Nat Rev Neurosci 2004;5:553Y564.
29. Biton V. Clinical pharmacology and mechanism of action of zonisamide. Clin Neuropharmacol 2007;30:230Y240.
30. Ait-Daoud N, Malcolm RJ, Johnson BA. An overview of medications for the treatment of alcohol withdrawal and alcohol dependence with an emphasis on the use of older and newer anticonvulsants. Addict Behav 2006;31:1628Y1649.
31. Dodgson SJ, Shank RP, Maryanoff BE. Topiramate as an inhibitor of carbonic anhydrase isoenzymes. Epilepsia 2000;41(suppl 1): S35YS39.
32. Dessirier JM, Simons CT, Carstens MI, et al. Psychophysical and neurobiological evidence that the oral sensation elicited by carbonated water is of chemogenic origin. Chem Senses 2000;25: 277Y284.
33. Kinrys G, Vasconcelos e Sa D, Nery F. Adjunctive zonisamide for treatment refractory anxiety. Int J Clin Pract 2007;61: 1050Y1053.
34. Hammond EJ, Perchalski RJ, Wilder BJ. Neuropharmacology of zonisamide, a new antiepileptic drug. Gen Pharmacol 1987;18: 303Y307.